Early detection of pulmonary hypertension (PH) in infants with congenital heart disease (CHD) is crucial for timely intervention and management. Serum pentraxin 3 (PTX3) has emerged as a potential biomarker for inflammatory diseases, but its association with PH in the context of CHD has not been thoroughly investigated.
No takes yet. Share an insight, caveat, or question.
Somaia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: